2026.01.22 本实验室论文入选为ESI数据库高被引论文热烈祝贺本实验室论文： 1、Luo M, Zhou L, Huang Z, Li B, Nice EC, Xu J*, Huang C*. Antioxidant Therapy in Cancer: Rationale and Progress. Antioxidants (Basel). 2022 Jun 8;11(6):1128.（被引次数130次） 2、Tian H, Zhang T, Qin S, Huang Z, Zhou L, Shi J, Nice EC, Xie N*, Huang C*, Shen Z*. Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies. J Hematol Oncol. 2022 Sep 12;15(1):132.（被引次数307次） 3、Xie N, Shen G, Gao W, Huang Z, Huang C*, Fu L*. Neoantigens: promising targets for cancer therapy. Signal Transduct Target Ther. 2023 Jan 6;8(1):9.（被引次数642次） 4、Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu SG, Huang C*, Tang Y*. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther. 2021 Apr 28;6(1):162.（被引次数350次） 5、Zhou L, Zhang Z, Nice E, Huang C*, Zhang W*, Tang Y*. Circadian rhythms and cancers: the intrinsic links and therapeutic potentials. J Hematol Oncol. 2022 Mar 4;15(1):21.（被引次数106次） 6、Tian H, Cao J, Li B, Nice EC, Mao H*, Zhang Y*, Huang C*. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment. Bone Res. 2023 Feb 27;11(1):11.（被引次数156次） 7、Gao W, Huang Z, Duan J, Nice EC, Lin J*, Huang C*. Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A. Mol Oncol. 2021 Dec;15(12):3527-3544.（被引次数249次） 8、Li L, Peng P, Ding N, Jia W, Huang C*, Tang Y*. Oxidative Stress, Inflammation, Gut Dysbiosis: What Can Polyphenols Do in Inflammatory Bowel Disease? Antioxidants (Basel). 2023 Apr 20;12(4):967.（被引次数93次） 9、Jin P, Jiang J, Zhou L, Huang Z, Nice EC, Huang C*, Fu L*. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol. 2022 Jul 18;15(1):97.（被引次数175次） 10、Zhang P, Li T, Wu X, Nice EC, Huang C*, Zhang Y*. Oxidative stress and diabetes: antioxidative strategies. Front Med. 2020 Oct;14(5):583-600.（被引次数384次） 于2026年1月入选为ESI数据库高被引论文。
|
